Adverse Event Profile of Blinatumomab in Acute Lymphoblastic Leukemia
3 Mga view
• 08/04/23
0
0
I-embed
administrator
Mga subscriber
In this segment, Raoul Tibes, MD, PhD, highlights common toxicities to be aware of in patients with acute lymphoblastic leukemia receiving blinatumomab therapy.
Magpakita ng higit pa
Mga Komento sa Facebook
SORT BY-
Mga Nangungunang Komento
-
Pinakabagong komento